Who should be screened for pancreatic cancer, and when should it start?
In this episode of PancChat, host Alisyn Camerota speaks with leading experts Dr. Michael Goggins (Johns Hopkins) and Dr. Anirban Maitra (MD Anderson / NYU Langone) about identifying higher-risk individuals and creating personalized surveillance plans.
From genetic mutations like BRCA to family history, pancreatic cysts, and new-onset diabetes — the doctors break down what puts someone at increased risk — and how that translates into screening recommendations. They discuss the importance of working with specialized centers, the role of annual MRIs and endoscopic ultrasounds, and why starting surveillance around age 50 (or earlier for some genetic conditions) can be potentially life-saving.
Whether you have a family history, carry a genetic mutation, or are navigating risk assessment for yourself or a loved one, this episode offers expert guidance to help you make informed decisions about pancreatic cancer surveillance.
Don’t forget to follow PancChat to get new episodes — delivered twice a month — right in your podcast feed. Available on all major platforms, wherever you get your podcasts.
Resources: